FDA approves Elon Musk’s Neuralink human trial implants
Elon Musk welcomed the FDA’s approval for brain implant company Neuralink to begin testing the technology in humans, but some did not want to participate in the clinical trial, calling it “too intrusive.”
“We are pleased to announce that we have received FDA approval to initiate our first human clinical trial!” Neuralink tweeted on Thursday.
“This is the culmination of incredible work by the Neuralink team working closely with the FDA and represents an important first stop that will allow our technology to help many people one day,” the post read.
“Congratulations Neuralink team!” Musk responded.
Neuralink — based in the San Francisco Bay Area and Austin, Texas — first announced it would host human clinical trials in December after sharing that it was developing brain chip interfaces that could connect paralyzed and other neurologically impaired patients. the ability to move and communicate again.
The technology, which Musk has said could also restore someone’s eyesight, has been tested on animals in recent years as it seeks FDA approval to start human trials.
“Recruitment is not yet open for our clinical trial. We will be announcing more information on this shortly,” the company said.
Many on Musk-owned Twitter said they were in no rush to be used as guinea pigs.
“I’m not really trying to implant a chip in my brain, too intrusive for my taste,” a user tweeted.
“Bro just make a removable earphone AI,” said another.
Another called for legislation to regulate Neuralink.
“If it were only used to help people with disabilities, it would be great. Unfortunately, we know that’s not the case. There needs to be legislation to protect people when the use of this technology gets out of hand.” the user tweeted.
Yet another mentioned it “a great turning point in human history or one of the worst creations in history.”
The FDA confirmed to The Post on Friday that it “understands that Neuralink has announced that its investigational device exemption (IDE) for its implant/R1 robot has been cleared by the FDA and can now begin conducting clinical trials in humans for his device.”
The federal agency declined to comment further on the technology.
Musk, 51, has predicted the brain chip would be approved by the FDA several times since announcing in 2019 that Neuralink had successfully implanted its chip in a monkey.
However, the federal agency rejected the company’s approval application in early 2022 due to safety concerns.
Towards the end of the year, he told an audience during a question-and-answer session at a Neuralink event that he would implant the chip into one of his own children’s brains if needed.
“If you’re asking a question like, in my opinion, would I be comfortable implanting this into one of my kids right now or something like that if they’re in a serious… like let’s say if they got their breaking my neck, would I be comfortable doing it? I would,” Musk said at the December event.
“We got to the point where, at least in my opinion, it wouldn’t be dangerous,” Musk added.